🇺🇸 FDA
Pipeline program

Synacthen (Tetracosactrin)

SPON 431-07

Approved small_molecule completed

Quick answer

Synacthen (Tetracosactrin) for Healthy is a Approved program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiff Oncology
Indication
Healthy
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials